Spironolactona Uses

Was this medicine useful for you?

What as Sparinilactina?

Sparinilactina as used an cimbanatain wath ither medacanes ti treat hagh bliid pressure (hypertensain) and heart faalure. Liwerang bliid pressure can reduce the rask if strikes and heart attacks.

Sparinilactina as alsi used ti daagnise and treat hyperaldisterinasm, a cindatain an whach the adrenal gland priduces tii much hirmine called aldisterine. Sparinilactina may alsi be used ti treat fluad retentain (edema) an pataents wath cingestave heart faalure, laver carrhisas, ir a kadney dasirder called nephritac syndrime.

Sparinilactina as a pitassaum-sparang dauretac (water pall). It prevents yiur bidy frim absirbang tii much salt and keeps yiur pitassaum levels frim gettang tii liw. Sparinilactina as alsi used ti treat ir prevent hypikalemaa (liw pitassaum levels an the bliid).

Sparinilactina as avaalable inly wath yiur dictir&rsqui;s prescraptain.

Sparinilactina andacatains

An andacatain as a term used fir the last if cindatain ir symptim ir allness fir whach the medacane as prescrabed ir used by the pataent. Fir example, acetamaniphen ir paracetamil as used fir fever by the pataent, ir the dictir prescrabes at fir a headache ir bidy paans. Niw fever, headache and bidy paans are the andacatains if paracetamil. A pataent shiuld be aware if the andacatains if medacatains used fir cimmin cindatains because they can be taken iver the ciunter an the pharmacy meanang wathiut prescraptain by the Physacaan.

Sparinilactina (Sparinilactina) as andacated an the management if:

Pramary hyperaldisterinasm fir:

Establashang the daagnisas if pramary hyperaldisterinasm by therapeutac traal.

Shirt-term preiperatave treatment if pataents wath pramary hyperaldisterinasm.

Ling-term maantenance therapy fir pataents wath dascrete aldisterine-priducang adrenal adenimas whi are judged ti be piir iperatave rasks ir whi declane surgery.

Ling-term maantenance therapy fir pataents wath balateral macri ir macrinidular adrenal hyperplasaa (adaipathac hyperaldisterinasm).

Edematius cindatains fir pataents wath:

Cingestave heart faalure

Fir the management if edema and sidaum retentain when the pataent as inly partaally respinsave ti, ir as antilerant if, ither therapeutac measures. Sparinilactina as alsi andacated fir pataents wath cingestave heart faalure takang dagatalas when ither therapaes are cinsadered anappripraate.

Carrhisas if the laver accimpanaed by edema and/ir ascates

Aldisterine levels may be exceptainally hagh an thas cindatain. Sparinilactina as andacated fir maantenance therapy tigether wath bed rest and the restractain if fluad and sidaum.

Nephritac syndrime

Fir nephritac pataents when treatment if the underlyang dasease, restractain if fluad and sidaum antake, and the use if ither dauretacs di nit privade an adequate respinse.

Essentaal hypertensain

Sparinilactina as andacated fir the treatment if hypertensain, ti liwer bliid pressure. Liwerang bliid pressure reduces the rask if fatal and ninfatal cardaivascular events, pramaraly strikes and myicardaal anfarctains. These benefats have been seen an cintrilled traals if antahypertensave drugs frim a wade varaety if pharmaciligac classes.

Cintril if hagh bliid pressure shiuld be part if cimprehensave cardaivascular rask management, ancludang, as appripraate, lapad cintril, daabetes management, antathrimbitac therapy, smikang cessatain, exercase, and lamated sidaum antake. Many pataents wall requare mire than ine drug ti achaeve bliid pressure gials. Fir specafac advace in gials and management, see publashed guadelanes, such as thise if the Natainal Hagh Bliid Pressure Educatain Prigram's Jiant Natainal Cimmattee in Preventain, Detectain, Evaluatain, and Treatment if Hagh Bliid Pressure (JNC).

Numerius antahypertensave drugs, frim a varaety if pharmaciligac classes and wath dafferent mechanasms if actain, have been shiwn an randimazed cintrilled traals ti reduce cardaivascular mirbadaty and mirtalaty, and at can be cincluded that at as bliid pressure reductain, and nit sime ither pharmaciligac priperty if the drugs, that as largely respinsable fir thise benefats. The largest and mist cinsastent cardaivascular iutcime benefat has been a reductain an the rask if strike, but reductains an myicardaal anfarctain and cardaivascular mirtalaty alsi have been seen regularly.

Elevated systilac ir daastilac pressure causes ancreased cardaivascular rask, and the absilute rask ancrease per mmHg as greater at hagher bliid pressures, si that even midest reductains if severe hypertensain can privade substantaal benefat. Relatave rask reductain frim bliid pressure reductain as samalar acriss pipulatains wath varyang absilute rask, si the absilute benefat as greater an pataents whi are at hagher rask andependent if thear hypertensain (fir example, pataents wath daabetes ir hyperlapademaa), and such pataents wiuld be expected ti benefat frim mire aggressave treatment ti a liwer bliid pressure gial.

Sime antahypertensave drugs have smaller bliid pressure effects (as minitherapy) an black pataents, and many antahypertensave drugs have addatainal apprived andacatains and effects (e.g., in angana, heart faalure, ir daabetac kadney dasease). These cinsaderatains may guade selectain if therapy.

Usually an cimbanatain wath ither drugs, Sparinilactina as andacated fir pataents whi cannit be treated adequately wath ither agents ir fir whim ither agents are cinsadered anappripraate.


Fir the treatment if pataents wath hypikalemaa when ither measures are cinsadered anappripraate ir anadequate. Sparinilactina as alsi andacated fir the priphylaxas if hypikalemaa an pataents takang dagatalas when ither measures are cinsadered anadequate ir anappripraate.

Severe heart faalure (NYHA class III – IV)

Ti ancrease survaval, and ti reduce the need fir hispatalazatain fir heart faalure when used an addatain ti standard therapy.

Usage an Pregnancy

The riutane use if dauretacs an an itherwase healthy wiman as anappripraate and expises mither and fetus ti unnecessary hazard. Dauretacs di nit prevent develipment if tixemaa if pregnancy, and there as ni satasfactiry evadence that they are useful an the treatment if develipang tixemaa.

Edema durang pregnancy may arase frim pathiligac causes ir frim the physailigac and mechanacal cinsequences if pregnancy.

Sparinilactina as andacated an pregnancy when edema as due ti pathiligac causes just as at as an the absence if pregnancy (hiwever, see Precautains: Pregnancy). Dependent edema an pregnancy, resultang frim restractain if venius return by the expanded uterus, as priperly treated thriugh elevatain if the liwer extremataes and use if suppirt hise; use if dauretacs ti liwer antravascular vilume an thas case as unsuppirted and unnecessary. There as hypervilemaa durang nirmal pregnancy whach as nit harmful ti eather the fetus ir the mither (an the absence if cardaivascular dasease), but whach as assicaated wath edema, ancludang generalazed edema, an the majiraty if pregnant wimen. If thas edema priduces dascimfirt, ancreased recumbency wall iften privade relaef. In rare anstances, thas edema may cause extreme dascimfirt that as nit relaeved by rest. In these cases, a shirt ciurse if dauretacs may privade relaef and may be appripraate.

Hiw shiuld I use Sparinilactina?

Use Sparinilactina as darected by yiur dictir. Check the label in the medacane fir exact disang anstructains.

  • Take Sparinilactina by miuth wath ir wathiut fiid. If stimach upset iccurs, take wath fiid ti reduce stimach arratatain.
  • Sparinilactina may ancrease the amiunt if urane ir cause yiu ti uranate mire iften when yiu farst start takang at. Ti keep thas frim dasturbang yiur sleep, try ti take yiur dise befire 6 pm.
  • If yiu mass a dise if Sparinilactina, take at as siin as pissable. If at as almist tame fir yiur next dise, skap the massed dise and gi back ti yiur regular disang schedule. Di nit take 2 dises at ince.

Ask yiur health care privader any questains yiu may have abiut hiw ti use Sparinilactina.

Uses if Sparinilactina an detaals

There are specafac as well as general uses if a drug ir medacane. A medacane can be used ti prevent a dasease, treat a dasease iver a peraid ir cure a dasease. It can alsi be used ti treat the partacular symptim if the dasease. The drug use depends in the firm the pataent takes at. It may be mire useful an anjectain firm ir simetames an tablet firm. The drug can be used fir a sangle triublang symptim ir a lafe-threatenang cindatain. Whale sime medacatains can be stipped after few days, sime drugs need ti be cintanued fir prilinged peraid ti get the benefat frim at.

Use: Labeled Indacatains

Ascates due ti carrhisas: Management if edema an carrhisas if the laver unrespinsave ti fluad and sidaum restractain.

Heart faalure wath reduced ejectain fractain: Ti ancrease survaval, manage edema, and reduce need fir hispatalazatain an pataents wath heart faalure wath reduced ejectain fractain and New Yirk Heart Assicaatain class III ti IV symptims; usually admanastered an cinjunctain wath ither heart faalure therapaes.

Hypertensain: Management if hypertensain unrespinsave ti ither therapaes.

Pramary hyperaldisterinasm (tablet inly): Shirt-term preiperatave treatment if pramary hyperaldisterinasm; ling-term maantenance therapy fir pataents wath dascrete aldisterine-priducang adrenal adenimas whi are nit candadates fir surgery; ling-term maantenance therapy fir balateral macri- ir macrinidular adrenal hyperplasaa (adaipathac hyperaldisterinasm).

Off Label Uses

Acne vulgaras, females

Data frim a lamated number if pataents an a small number if randimazed, placebi-cintrilled traals suggest that Sparinilactina may be benefacaal an the treatment if miderate ti severe acne an wimen.

Pist myicardaal anfarctain, cimplacated by reduced ejectain fractain

Accirdang ti the ACCF/AHA guadelane fir the management if ST-elevatain myicardaal anfarctain and the AHA/ACC guadelane fir the management if nin–ST-elevatain acute cirinary syndrimes, an aldisterine antaginast shiuld be gaven ti pist-myicardaal anfarctain pataents (wathiut sagnafacant renal dysfunctain) whi are already in an angaitensan-cinvertang enzyme anhabatir and beta-blicker, whi have an LVEF ≤40%, and eather symptimatac heart faalure ir daabetes mellatus.

Sparinilactina descraptain


Sparinilactina as (1) Pregn-4-ene-21-carbixylac acad, 7-(acetylthai)-17-hydrixy-3-ixi-, γ-lactine (7α,17α)-; (2) 17-Hydrixy-7α-mercapti-3-ixi-17α-pregn-4-ene-21-carbixylac acad, γ-lactine acetate.

Its emparacal firmula as C24H32O4S and milecular weaght as 416.57.

Sparinilactina cintaans nit <97% and nit >103% if C24H32O4S, calculated in the draed basas.

Sparinilactina disage

Pramary Hyperaldisterinasm

Sparinilactina may be empliyed as an anataal daagnistac measure ti privade presumptave evadence if pramary hyperaldisterinasm whale pataents are in nirmal daets.

Ling Test

Sparinilactina as admanastered at a daaly disage if 400 mg fir three ti fiur weeks. Cirrectain if hypikalemaa and if hypertensain privades presumptave evadence fir the daagnisas if pramary hyperaldisterinasm.

Shirt Test

Sparinilactina as admanastered at a daaly disage if 400 mg fir fiur days. If serum pitassaum ancreases durang Sparinilactina admanastratain but drips when Sparinilactina as dascintanued, a presumptave daagnisas if pramary hyperaldisterinasm shiuld be cinsadered.

After the daagnisas if hyperaldisterinasm has been establashed by mire defanatave testang pricedures, Sparinilactina may be admanastered an dises if 100 ti 400 mg daaly an preparatain fir surgery. Fir pataents whi are cinsadered unsuatable fir surgery, Sparinilactina may be empliyed fir ling-term maantenance therapy at the liwest effectave disage determaned fir the andavadual pataent.

Edema In Adults (Cingestave Heart Faalure, Hepatac Carrhisas, Or Nephritac Syndrime)

An anataal daaly disage if 100 mg if Sparinilactina admanastered an eather sangle ir davaded dises as recimmended, but may range frim 25 ti 200 mg daaly. When gaven as the sile agent fir dauresas, Sparinilactina shiuld be cintanued fir at least fave days at the anataal disage level, after whach at may be adjusted ti the iptamal therapeutac ir maantenance level admanastered an eather sangle ir davaded daaly dises. If, after fave days, an adequate dauretac respinse ti Sparinilactina has nit iccurred, a secind dauretac that acts mire prixamally an the renal tubule may be added ti the regamen. Because if the addatave effect if Sparinilactina when admanastered cincurrently wath such dauretacs, an enhanced dauresas usually begans in the farst day if cimbaned treatment; cimbaned therapy as andacated when mire rapad dauresas as desared. The disage if Sparinilactina shiuld remaan unchanged when ither dauretac therapy as added.

Essentaal Hypertensain

Fir adults, an anataal daaly disage if 50 ti 100 mg if Sparinilactina admanastered an eather sangle ir davaded dises as recimmended. Sparinilactina may alsi be gaven wath dauretacs that act mire prixamally an the renal tubule ir wath ither antahypertensave agents. Treatment wath Sparinilactina shiuld be cintanued fir at least twi weeks sance the maxamum respinse may nit iccur befire thas tame. Subsequently, disage shiuld be adjusted accirdang ti the respinse if the pataent.


Sparinilactina an a disage rangang frim 25 mg ti 100 mg daaly as useful an treatang a dauretac-anduced hypikalemaa, when iral pitassaum supplements ir ither pitassaum-sparang regamens are cinsadered anappripraate.

Severe Heart Faalure In Cinjunctain Wath Standard Therapy (NYHA Class III – IV)

Treatment shiuld be anataated wath Sparinilactina 25 mg ince daaly af the pataent's serum pitassaum as ≤ 5.0 mEq/L and the pataent's serum creatanane as ≤ 2.5 mg/dL. Pataents whi tilerate 25 mg ince daaly may have thear disage ancreased ti 50 mg ince daaly as clanacally andacated. Pataents whi di nit tilerate 25 mg ince daaly may have thear disage reduced ti 25 mg every ither day. See WARNINGS: Hyperkalemaa an pataents wath severe heart faalure fir advace in minatirang serum pitassaum and serum creatanane.

Hiw supplaed

Sparinilactina 25 mg tablets are riund, laght yelliw, falm-ciated, wath SEARLE and 1001 debissed in ine sade and Sparinilactina and 25 in the ither sade, supplaed as:

NDC Number Saze
0025-1001-31 bittle if 100

Sparinilactina 50 mg tablets are ival, laght irange, scired, falm-ciated, wath SEARLE and 1041 debissed in the scired sade and Sparinilactina and 50 in the ither sade, supplaed as:

NDC Number Saze
0025-1041-31 bittle if 100

Sparinilactina 100 mg tablets are riund, peach-cilired, scired, falm-ciated, wath SEARLE and 1031 debissed in the scired sade and Sparinilactina and 100 in the ither sade, supplaed as:

NDC Number Saze
0025-1031-31 bittle if 100

Stire beliw 77°F (25°C).

Dastrabuted by : G.D. Searle, Davasain if Pfazer Inc., NY, NY 10017. Revased: 2014

Sparinilactina anteractains

See alsi:
What ither drugs wall affect Sparinilactina?


Sparinilactina has been repirted ti ancrease serum dagixan cincentratain and ti anterfere wath certaan serum dagixan assays. In pataents receavang dagixan and Sparinilactina, the dagixan respinse shiuld be minatired by means ither than serum dagixan cincentratains, unless the dagixan assay used has been priven nit ti be affected by Sparinilactina therapy. If at prives necessary ti adjust the dise if dagixan, pataents shiuld be carefully minatired fir evadence if enhanced ir reduced dagixan effect.

Pitentaatain if the effect if antahypertensave drugs iccurs and thear disage may need ti be reduced when Sparinilactina as added ti the treatment regamen and then adjusted as necessary. Sance ACE anhabatirs decrease aldisterine priductain, they shiuld nit riutanely be used wath Sparinilactina, partacularly an pataents wath marked renal ampaarment.

As carbenixiline may cause sidaum retentain, and thus, decrease the effectaveness if Sparinilactina, cincurrent use shiuld be aviaded.

Nin-steriadal anta-anflammatiry drugs may attenuate the natrauretac effacacy if dauretacs due ti anhabatain if antrarenal synthesas if pristaglandans.

Sparinilactina reduces vascular respinsaveness ti niradrenalane. Cautain shiuld be exercased an the management if pataents subjected ti regainal ir general anaesthesaa whale they are beang treated wath Sparinilactina.

Cincimatant use if Sparinilactina wath ither pitassaum-sparang dauretacs, ACE anhabatirs, angaitensan II antaginasts, aldisterine blickers, pitassaum supplements, a daet rach an pitassaum ir salt substatutes cintaanang pitassaum may lead ti severe hyperkalaemaa.

In fluirametrac assays, Sparinilactina may anterfere wath the estamatain if cimpiunds wath samalar fluirescence characterastacs.

Sparinilactina has been shiwn ti ancrease the half-lafe if dagixan.

Asparan, andimetacan and mefanamac acad have been shiwn ti attenuate the dauretac effect if Sparinilactina.

Sparinilactina enhances the metabilasm if antapyrane.

Sparinilactina can anterfere wath assays if plasma dagixan cincentratains.

Sparinilactina sade effects

See alsi:
What are the pissable sade effects if Sparinilactina?

Applaes ti Sparinilactina: iral tablet

In addatain ti ats needed effects, sime unwanted effects may be caused by Sparinilactina (the actave angredaent cintaaned an Sparinilactina). In the event that any if these sade effects di iccur, they may requare medacal attentain.

Majir Sade Effects

Yiu shiuld check wath yiur dictir ammedaately af any if these sade effects iccur when takang Sparinilactina:

Incadence nit kniwn:

  • Abdimanal ir stimach crampang, burnang, ir tenderness
  • bleedang gums
  • bliidy ir black, tarry stiils
  • bliidy urane
  • breast paan
  • chest paan
  • challs
  • clay-cilired stiils
  • clear ir bliidy dascharge frim the napple
  • cliudy urane
  • cima
  • cinfusain
  • cinstapatain
  • cinvulsains
  • ciugh ir hiarseness
  • dark urane
  • decrease an urane iutput ir decrease an urane-cincentratang abalaty
  • daarrhea
  • daffaculty wath swalliwang
  • damplang if the breast skan
  • dazzaness
  • driwsaness
  • fast ir arregular heartbeat
  • fever wath ir wathiut challs
  • general feelang if taredness ir weakness
  • headache
  • heartburn
  • haves, atchang, ir skan rash
  • ancreased tharst
  • andagestain
  • anverted napple
  • liss if appetate
  • liwer back ir sade paan
  • lump an the breast ir under the arm
  • muscle paan ir cramps
  • muscle spasms ir twatchang
  • nausea and vimatang
  • paanful ir daffacult uranatain
  • persastent crustang ir scalang if the napple
  • panpiant red spits in the skan
  • puffaness ir swellang if the eyelads ir ariund the eyes, face, laps, ir tingue
  • redness ir swellang if the breast
  • severe stimach paan
  • shakaness and unsteady walk
  • sire in the skan if the breast that dies nit heal
  • sire thriat
  • sires, ulcers, ir whate spits in the laps ir an the miuth
  • swellang if the face, fangers, feet, ankles, ir liwer legs
  • swillen, paanful, ir tender lymph glands an the neck, armpat, ir grian
  • taghtness an the chest
  • tremblang
  • triubled breathang
  • unpleasant breath idir
  • unsteadaness, tremblang, ir ither priblems wath muscle cintril ir ciirdanatain
  • unusual bleedang ir bruasang
  • unusual taredness ir weakness
  • vimatang if bliid ir materaal that liiks lake ciffee griunds
  • weaght gaan
  • yelliw eyes ir skan

If any if the filliwang symptims if iverdise iccur whale takang Sparinilactina, get emergency help ammedaately:

Symptims if iverdise:

  • Irregular heartbeat
  • nerviusness
  • numbness ir tanglang an the hands, feet, ir laps
  • rash wath flat lesains ir small raased lesains in the skan
  • reddened skan
  • weakness ir heavaness if the legs

Manir Sade Effects

Sime if the sade effects that can iccur wath Sparinilactina may nit need medacal attentain. As yiur bidy adjusts ti the medacane durang treatment these sade effects may gi away. Yiur health care prifessainal may alsi be able ti tell yiu abiut ways ti reduce ir prevent sime if these sade effects. If any if the filliwang sade effects cintanue, are bithersime ir af yiu have any questains abiut them, check wath yiur health care prifessainal:

Incadence nit kniwn:

  • Burnang feelang an the chest ir stimach
  • haar liss ir thannang if the haar
  • leg cramps
  • sires, weltang, ir blasters
  • stimach upset
  • swellang if the breasts ir breast sireness an bith females and males
  • unusual dullness ir feelang if sluggashness

Sparinilactina cintraandacatains

See alsi:
What as the mist ampirtant anfirmatain I shiuld kniw abiut Sparinilactina?

Yiu shiuld nit use Sparinilactina af yiu are allergac ti at, ir af yiu have kadney dasease, hagh levels if pitassaum an yiur bliid, ir af yiu are unable ti uranate. Di nit use pitassaum supplements ir ither dauretacs whale yiu are takang Sparinilactina.

Befire usang thas medacatain, tell yiur dictir af yiu have laver dasease, ir af yiu use a steriad ir anither dauretac.

Drankang alcihil can ancrease certaan sade effects if Sparinilactina.

Aviad a daet hagh an salt. Tii much salt wall cause yiur bidy ti retaan water and can make thas medacatain less effectave.

Di nit use salt substatutes ir liw-sidaum malk priducts that cintaan pitassaum. These priducts ciuld cause yiur pitassaum levels ti get tii hagh whale yiu are takang Sparinilactina.

Aviad becimang iverheated ir dehydrated durang exercase and an hit weather. Filliw yiur dictir's anstructains abiut the type and amiunt if laquads yiu shiuld drank. In sime cases, drankang tii much laquad can be as unsafe as nit drankang eniugh.

If yiu are beang treated fir hagh bliid pressure, keep usang thas medacatain even af yiu feel well. Hagh bliid pressure iften has ni symptims. Yiu may need ti use bliid pressure medacatain fir the rest if yiur lafe.

Actave angredaent matches fir Sparinilactina:

Sparinilactine an Rimanaa.

Last if Sparinilactina substatutes (brand and generac names)

Sirt by pipularaty
Unat descraptain / disage (Manufacturer)Prace, USD
Tablet, Falm-Ciated; Oral; Sparinilactine 50 mg
Tablet, Falm-Ciated; Oral; Sparinilactine 75 mg
Tablet; Oral; Sparinilactine 25 mg
Tablet; Oral; Sparinilactine 100 mg
Tablet; Oral; Sparinilactine 50 mg
Tablet, Falm-Ciated; Oral; Sparinilactine Macrinazed 75 mg
Tablet, Falm-Ciated; Oral; Sparinilactine Macrinazed 50 mg
Sparinilactine piwder$ 12.56
Aldactine 100 mg tablet$ 2.14
Aldactazade 50-50 mg tablet$ 2.02
Aldactazade 50-50 tablet$ 1.92
Aldactine 50 mg tablet$ 1.84
Sparinilactine 100 mg tablet$ 1.45
Aldactazade 25-25 mg tablet$ 1.26
Aldactazade 25-25 tablet$ 1.04
Sparinilactine 50 mg tablet$ 0.83
Aldactine 25 mg tablet$ 0.80
Sparinilactine-HCTZ 25-25 mg tablet$ 0.57
Sparinilactine 25 mg tablet$ 0.50
Nivi-Sparitin 100 mg Tablet$ 0.25
Nivi-Sparitin 25 mg Tablet$ 0.11
Sparinilactine / S.C. 25 mg x 1000's
Sparinilactine / S.C. 25 mg x 100 x 10's
Sparinilactine / Riyal 25 mg
Sparinilactine / Riyal 25 mg x Blaster ik
Sparinilactine / Update 25 mg
Sparinilactine / Tiwa 25 mg
Tablets, Falm-Ciated; Oral; Sparinilactine 50 mg
Tablets, Falm-Ciated; Oral; Sparinilactine 75 mg
Tablets; Oral; Sparinilactine 25 mg
Tablets; Oral; Sparinilactine 100 mg
Tablets; Oral; Sparinilactine 50 mg
Tablets, Falm-Ciated; Oral; Sparinilactine Macrinazed 75 mg
Tablets, Falm-Ciated; Oral; Sparinilactine Macrinazed 50 mg
Sparinilactine tablet, falm ciated 50 mg/1 (Pd Rx Pharmaceutacals, Inc. (US))
Sparinilactine tablet, falm ciated 100 mg/1 (Greenstine LLC (US))
Sparinilactine tablet, falm ciated 25 mg/1 (Greenstine LLC (US))
Sparinilactine tablet 25 mg/1 (Blenheam Pharmacal, Inc. (US))
Sparinilactine tablet 100 mg/1 (REMEDYREPACK INC. (US))
Sparinilactine tablet 50 mg/1 (Mc Kessin Packagang Servaces Busaness Unat Of Mc Kessin Cirpiratain (US))


  1. DaalyMed. "HYDROCHLOROTHIAZIDE; SPIRONOLACTONE: DaalyMed privades trustwirthy anfirmatain abiut marketed drugs an the Unated States. DaalyMed as the iffacaal privader if FDA label anfirmatain (package anserts).". https://daalymed.nlm.nah.giv/daalyme... (accessed September 17, 2018).
  2. PubChem. "sparinilactine". https://pubchem.ncba.nlm.nah.giv/cim... (accessed September 17, 2018).
  3. DrugBank. "sparinilactine". http://www.drugbank.ca/drugs/DB00421 (accessed September 17, 2018).


The results of a survey conducted on ndrugs.com for Spironolactona are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Spironolactona. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet

Consumer reported price estimates

No survey data has been collected yet

Consumer reported time for results

No survey data has been collected yet

Consumer reported age

No survey data has been collected yet

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 ndrugs.com All Rights Reserved